Absolute CK-MB vs. CK-MB Relative Index for Cardiac Risk
Over one year, 2028 patients (mean age, 52.7; 59.9% women) were prospectively enrolled. Samples for CK-MB testing were obtained at the time of presentation.
Biomarkers as Predictors of Outcome After Cardiac Arrest
Expert Rev Clin Pharmacol. 2012;5(6):687-699. CK is an enzyme that consumes ATP to create phosphocreatine from creatine; phosphocreatine can be used as a generator of ATP in the tissues that ...
Elevated CK Levels Found in Pneumonia - Medscape
Mar 12, 2004 · Question. Some patients presenting with pneumonia have elevated creatine kinase (CK) levels. What is the pathophysiology behind this, and does this finding have any clinical relevance?
Latest Medical News, Clinical Trials, Guidelines - Medscape
Apr 18, 2025 · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Digestive Disease Week 2007 (DDW) - Medscape
4 days ago · John Baillie, MB, ChB, FRCP, FASGE, addresses topical issues in the diagnosis and treatment of pancreaticobiliary disease, as based on key sessions at DDW 2007. ... Plasma levels of cytokeratin-18 ...
Diabetes & Endocrinology - Medscape
Apr 17, 2025 · Diabetes & Endocrinology : Welcome to Medscape Diabetes & Endocrinology, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text ...
Semaglutide Significantly Improves Chronic Kidney Disease
May 24, 2024 · STOCKHOLM — Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in preventing major kidney disease, cardiovascular events, as well as mortality in ...
Majority of Adults At Risk for CKM Syndrome - Medscape
May 8, 2024 · TOPLINE: Nearly 90% of adults were at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome between 2011 and 2020, according to new research published in JAMA.. METHODOLOGY:
Developing Oral Probiotics From Streptococcus salivarius
Philip A Wescombe 1, John DF Hale 1, Nicholas CK Heng 2 & John R Tagg* 1, 3 1 BLIS Technologies Ltd. Centre for Innovation, PO Box 56, Dunedin, 9054, New Zealand
Global Prevalence of Diabetes: Estimates for the Year 2000
Abstract and Introduction. Objective: The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030. Research Design ...